Latest Headlines

  1. Ribbon-Cutting Ceremonies Mark Opening Of New Global Headquarters In Lincolnshire For Flexan, LLC.
    6/9/2017

    Officials and employees with Flexan, LLC participated in ribbon-cutting ceremonies today, officially marking the move for the contract manufacturer’s global headquarters to north suburban Lincolnshire. The move continues FMI’s expansion in response to growth in the silicone contract manufacturing market for medical devices.

  2. MKS' Ophir® Business Unit Announces Large Array Laser Beam Profiling Camera With Quick And Easy USB Interfacing
    6/1/2017

    MKS Instruments, Inc., a global provider of technologies that enable advanced processes and improve productivity, has announced the Ophir® Pyrocam™ IV USB, a laser beam profiling camera that allows users to see their laser beam for dynamic alignment and proper operation. The camera features a 320 x 320 pixel pyroelectric array that can profile beams up to 1 inch (25 mm) without the need for reduction optics. It also includes a new USB 3.0 interface that provides a quick and easy connection to PCs for beam analysis, 2D and 3D beam display, as well as trending, data logging, and storage.

  3. Cook Medical’s Esophogeal Repair Device For Infants Cleared By FDA
    5/12/2017

    The U.S. Food and Drug Administration today authorized use of the Flourish Pediatric Esophageal Atresia Anastomosis, a first-of-its-kind medical device to treat infants up to one year old for a birth defect that causes a gap in their esophagus, called esophageal atresia.

  4. Medtronic Options QT Vascular’s Chocolate PTA Balloon Catheter
    5/11/2017

    QT Vascular Ltd., (the "Company" or "QT Vascular", and together with its subsidiaries, the "Group"), a global company engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of vascular disease, announced today that it has entered into an asset purchase option agreement ("Option Agreement") with Medtronic, for the acquisition of the Group's non-drug coated Chocolate® PTA.

  5. Siemens Healthineers, Imricor Team On Integrated Solution To Treat Arrhythmia
    5/10/2017

    Siemens Healthineers is joining forces with U.S.-based Imricor Medical Systems Inc. to develop an integrated solution that combines the clinical benefits of real-time MRI scans with 3D-guided cardiac ablation.

  6. Medtronic’s Quadripolar CRT-Ps Gain FDA Approval
    5/10/2017

    Medtronic plc has received U.S. Food and Drug Administration (FDA) approval for a portfolio of quadripolar cardiac resynchronization therapy-pacemakers (CRT-Ps) that improve therapy delivery for patients with heart failure.

  7. Boston Scientific’s Resonate ICDs, CRT-Ds Gain FDA Approval
    5/9/2017

    Boston Scientific (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval for the Resonate™ family of implantable cardioverter defibrillator (ICD) and cardiac resynchronization therapy defibrillator (CRT-D) systems.

  8. BD, UniteOR Collaborate On Integrated Tracking Solution For Operating Rooms
    5/9/2017

    BD (Becton, Dickinson and Company), a leading global medical technology company and UniteOR, Inc., announced recently the integration between BD’s IMPRESS instrument management system and UniteOR’s cloud-based surgical tray tracking and vendor management solution, that enables greater visibility of surgical tray management to health care workers in the operating room and sterile processing department.

  9. Abbott’s Sensor-Enabled Ablation Catheter Gains CE Mark Approval
    5/9/2017

    Abbott (NYSE: ABT) today announced CE Mark of the TactiCath™ Contact Force Ablation Catheter, Sensor Enabled™, developed to make it easier for physicians to more effectively treat atrial fibrillation (AF), a condition in which the upper chambers of the heart beat too fast.

  10. Cardiff Intl. To Acquire Prostate Dx Device Maker MedicaMetrix
    5/9/2017

    Cardiff International, Inc. (OTCQB: CDIF) and MedicaMetrix®, Inc. (Private; "MedicaMetrix") announced today they have signed a Letter of Intent agreement under which MedicaMetrix will merge into Cardiff International as its subsidiary, MedicaMetrix, Inc., in an all-stock transaction valued at approximately $6 million.